IBS Research Center Wins $7.5M to Find Out Why Women Suffer More
UCLA Health won $7. 5 million to renew a center studying why women with irritable bowel syndrome report more severe symptoms than men.
UCLA Health won $7. 5 million to renew a center studying why women with irritable bowel syndrome report more severe symptoms than men.
A pooled analysis of 17,368 adults ties Mediterranean, DASH and MIND eating to better thinking skills in snapshots, but the over-time results are mostly null.
The FDA approved Teva's Weltruza, a once-monthly subcutaneous olanzapine injection for adults with schizophrenia. Here is what it offers and what is still unknown.
HHS Secretary Robert F. Kennedy Jr. opened a clinic at NIH to treat and study people who report problems after vaccination. Experts are divided, and key details are still missing.
Viatris will buy Pacira BioSciences for $36.50 a share in cash, about $1.65 billion, in a bet on non-opioid pain drugs. Here is how the deal works and what comes…
The FDA gave AbbVie's experimental drug Temab-A two breakthrough therapy designations in colorectal and lung cancer. It speeds development, but it is not an approval.
A new Neurology study links more physical activity to slower declines in movement and memory in Parkinson's patients. Here's what it shows and what's still unknown.
The Washington Post reports the Trump administration is drafting a plan to allow temporary sales of some unapproved peptides. Nothing is official yet.
Stroke has long carried a reputation as a medical emergency that mainly affects older adults. New research suggests that picture is changing. A University of Cincinnati-led study found a sharp…
By THIS Newsroom | September 14, 2026 COVID-19 is once again climbing across the United States, and several schools have already experienced enough illness to temporarily shut their doors. The…
WASHINGTON, D.C. — President Donald Trump announced a new round of agreements with nine pharmaceutical manufacturers Monday, expanding his administration’s effort to bring U.S. prescription-drug prices closer to the lower prices…
Moderna just delivered the kind of clinical-trial result that can change the trajectory of a biotechnology company — and Wall Street reacted accordingly. Shares of Moderna (NASDAQ: MRNA) skyrocketed 177% on…
August 11, 2026 | Washington, D.C. President Donald Trump has signed a sweeping executive order that could significantly reshape federal childhood vaccine policy. The order emphasizes parental choice, informed consent…
Health stat of the day
Reader pollVote to see how readers answered
Daylight saving time: keep it, drop it or pick one.
Tap an answer to vote and see how other readers answered.
Reader pollVote to see how readers answered
For you and your family, honestly.
Tap an answer to vote and see how other readers answered.
Reader pollVote to see how readers answered
Be honest: we won't be offended.
Tap an answer to vote and see how other readers answered.
Translated automatically by Google. Names and quotes may not be perfect.
Voices come from your phone or computer. The ones marked ★ sound the most natural.
Look
Now playing